December 12 2016

The joint owners of Switzerland-based Unilabs, private
equity funds Apax Europe VI, Nordic Capital Fund VI ("Nordic
Capital") and Apax France VII, announced today that Nordic Capital
and Apax Partners France, have accepted an offer from Apax IX,
advised by Apax Partners LLP, for the acquisition of their
respective stakes in Unilabs. Financial terms of the transaction
are not being disclosed. Under the new ownership structure, Unilabs
will be able to continue to pursue its successful M&A strategy
and be at the forefront of the ongoing consolidation of the
European laboratory space.

The transaction marks the successful completion of the joint
ownership between funds advised by Apax Partners LLP, Nordic
Capital and Apax Partners France (jointly with Altamir), which saw
Unilabs taken private from the Swiss stock exchange in November
2007 and merged with the diagnostic division of pan-European
healthcare provider Capio in 2008.

Throughout the ownership, funds advised by Apax Partners LLP,
Nordic Capital, and Apax Partners France have made significant
investments into the business to pursue a shared vision of creating
what is today Europe's most modern and professionalised medical
laboratory business.

With over 112 laboratories and 43 medical imaging units across
10 European countries and emerging positions in the Middle East and
Latin America, Unilabs has grown to become one of Europe's leading
medical diagnostics businesses. Offering the most comprehensive
portfolio of diagnostic services in Europe, Unilabs' 5,300
employees provide reliable and actionable diagnostic information,
which is essential for effective treatment, thereby improving
patients' lives and contributing to the optimisation of rising
healthcare costs.

Having taken Unilabs to this unique position, Nordic Capital and
Apax Partners France have decided to sell their investment in
Unilabs to Apax IX, which will support the company as it takes
advantage of the strong market outlook and consolidation
opportunities.

Fredrik Näslund, Partner, NC Advisory AB, advisor to the Nordic
Capital Funds, said: "By drawing on a deep expertise and successful
track record in the healthcare sector, Nordic Capital has been able
support the creation of a truly market leading business. We would
like to thank Jos Lamers and the management team for their
dedication and commitment to driving the company's growth strategy
and development."

Echoing the support to Unilabs' management team, Bertrand Pivin,
partner at Apax Partners France, commented: "We are pleased to exit
in the knowledge that Unilabs, under the continued partnership with
Apax Partners LLP, will be ideally equipped to pursue its journey
and we wish them the best of success."

Driving a successful M&A strategy in a highly fragmented
European laboratory market by acquiring smaller and medium-sized
laboratories is critical to the future strategy of the business.
Unilabs will therefore continue to be at the forefront of the
ongoing consolidation of the European laboratory space.

Jos Lamers, CEO of Unilabs, commented: "I would like to thank
our partners for sharing our vision and for their support in
building a company with solid market leadership positions. Today's
transaction will allow us to pursue our ambition to become a
proactive partner to caregivers and patients in all areas of
diagnostics - from laboratory diagnostics to pathology and medical
imaging. We will achieve this by investing in innovative services,
pursuing operational excellence and conducting further M&A
activity to expand our European and international presence."

Steven Dyson, Partner at Apax Partners LLP, commented: "Under
the leadership of CEO Jos Lamers and his executive team, Unilabs
and its 5,300 employees have done an outstanding job in growing
organic revenues at close to double market rates, and they continue
to generate expanding operating margins. We are excited to continue
our successful collaboration and to support the company in its
future ambitions."

-------------------------------------------

About Unilabs
With over 112 laboratories and 43 imaging units and a broad
catalogue of more than 2,500 diagnostic tests, Unilabs is one of
Europe's leading providers of clinical laboratory testing and
medical diagnostic imaging services. Headquartered in Geneva, the
Unilabs Group services sectors ranging from private and public
healthcare providers to local governments, from pharmaceutical
companies to the general public. The Unilabs Group employs more
than 5,300 people worldwide, successfully operating laboratory and
medical diagnostic imaging facilities in 12 countries, and
generating annual revenues of €673m in 2015. Its network of
facilities provides its customers with one of the broadest
geographic footprints of any clinical laboratory and medical
diagnostic services provider in Europe. We are at the heart and
start of all effective treatment decisions: www.unilabs.com

About Nordic Capital
Nordic Capital private equity funds have invested in mid-market
companies primarily in the Nordic region since 1989. Through
committed ownership and by targeting strategic development and
operational improvements, Nordic Capital enables value creation in
its investments. Nordic Capital Funds invest in companies in
northern Europe and in selected investment opportunities
internationally. The most recent fund is Nordic Capital Fund
VIII with EUR 3.5 billion in committed capital, principally
provided by international institutional investors such as pension
funds. Nordic Capital Funds are based in Jersey, Channel Islands,
and are advised by the NC Advisory companies in Sweden, Denmark,
Finland, Norway, Germany and the UK. For further information: www.nordiccapital.com

About Apax Partners LLP
Apax Partners LLP is a leading global private equity advisory
firm. Over its more than 30-year history, Apax Partners LLP has
raised and advised funds with aggregate commitments in excess of
$48 billion*. Funds advised by Apax Partners LLP invest in
companies across four global sectors of Healthcare, Tech and Telco,
Services and Consumer. These funds provide long-term equity
financing to build and strengthen world-class companies. In the
healthcare sector they have completed more than 80 investments,
including in medical devices, pharmaceuticals and healthcare
services. For further information please see www.apax.com
*Funds raised since 1981, commitments converted from fund currency
to USD at FX rates as at September 30, 2016.

About Apax Partners France
Apax France is a leading private equity firm in French-speaking
European countries. With more than 40 years of experience, Apax
France provides long-term equity financing to build and strengthen
world-class companies. Funds managed and advised by Apax France
exceed €3 billion. These funds invest in fast-growing middle-market
companies across four sectors of specialisation. For further
information: www.apax.fr

About Altamir
Altamir is a listed private equity company (Euronext Paris-B, LTA)
with more than €650m in assets under management. The company
invests via and with the funds managed or advised by Apax Partners
France and Apax Partners LLP, two leading private equity firms in
their respective markets. It provides access to a diversified
portfolio of fast-growing companies across Apax's sectors of
specialisation (TMT, Retail & Consumer, Healthcare, Business
& Financial Services) and in complementary market segments
(mid-sized companies in French-speaking European countries and
larger companies across Europe, North America and key emerging
markets). For further information: www.altamir.fr

The transaction is subject to regulatory approvals and the parties
expect closing to occur in early 2017.

Rothschild & Co acted as M&A advisor to the Sellers on
the transaction.